MELISSA IVERSEN: Open Payments
NPI 1679711428 · MIDDLEPORT, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$811 in 52 payments from 10 companies in 2025. Trend: 2023 $741 · 2024 $698 · 2025 $811
Food & beverage: $811
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 39 | $555 |
| Abbott Laboratories | 2 | $47 |
| Lilly USA, LLC | 2 | $45 |
| AstraZeneca Pharmaceuticals LP | 2 | $41 |
| GlaxoSmithKline, LLC. | 2 | $32 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $19 |
| Dexcom, Inc. | 1 | $19 |
| E.R. Squibb & Sons, L.L.C. | 1 | $19 |
| Seqirus USA Inc | 1 | $18 |
| Amgen Inc. | 1 | $14 |
Products named: Ozempic, Rybelsus, Wegovy, FREESTYLE LIBRE 3, MOUNJARO, TRELEGY ELLIPTA, FARXIGA, Kerendia.
Industry payments across NY — which companies pay providers there.
